Loading...
The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
BACKGROUND: Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit. DESIGN: International, multi-centre, prospective, randomize...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2442584/ https://ncbi.nlm.nih.gov/pubmed/18559104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-9-37 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|